Anticancer Teamwork: Cross-Presenting Dendritic Cells Collaborate with Therapeutic Monoclonal Antibodies.

Details

Request a copyRequest a copy
Serval ID
serval:BIB_DF7D0310A078
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
UNIL/CHUV
Title
Anticancer Teamwork: Cross-Presenting Dendritic Cells Collaborate with Therapeutic Monoclonal Antibodies.
Journal
Cancer Discovery
Author(s)
Robert-Tissot C., Speiser D.E.
ISSN
2159-8290 (Electronic)
ISSN-L
2159-8274
Publication state
Published
Issued date
2016
Peer-reviewed
Oui
Volume
6
Number
1
Pages
17-19
Language
english
Notes
Publication types: Journal Article
Publication Status: ppublish
Abstract
Cross-presentation of tumor antigens represents a key pathway in antitumor immune responses that can be exploited to synergize not only with the already prominent "checkpoint blockade," but also with newer attempts to use T-cell stimulatory monoclonal antibodies in immunotherapy.
Keywords
Antibodies, Monoclonal/therapeutic use, Antigens, Neoplasm/metabolism, Dendritic Cells/immunology, Humans, Immunotherapy, Neoplasms/immunology, Neoplasms/therapy, T-Lymphocytes/immunology
OAI-PMH
oai:serval.unil.ch:BIB_DF7D0310A078
DOI
10.1158/2159-8290.CD-15-1366
Pubmed
26747893
Web of science
000372322500019
Open Access
Yes
Create date
12/04/2016 17:53
Last modification date
07/04/2021 6:34
Usage data